Artigos Científicos

BATISTUZZO, J.A; ITAYA, M; ETO, Y. Formulário Médico-Farmacêutico. São Paulo/SP:Tecnopress, 3ª Ed. 2006.

SWEETMAN, S.C; et al; MARTINDALE – Guia Completo de Consulta farmacoterapeutica. Barcelona. 2ª Ed. 2005.

Albright, C. D. Tsai A. Y. Friedrich C. B. Mar M. H. and Zeisel S. H. Choline availability alters embryonic development of the hippocampus and septum in the rat. Brain Res Dev Brain Res 1999;113:13-20.

Barbeau, A. Emerging treatments: replacement therapy with choline or lecithin in neurological diseases. Can.J.Neurol.Sci. 1978;5(1):157-160.

Cacabelos, R., Alvarez, X. A., Franco-Maside, A., Fernandez-Novoa, L., and Caamano, J. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Ann.N.Y.Acad.Sci. 9-24-1993;695:321-323.

Christie, J. G. Blackburn 1. M. Glen A. I. M. Zeisel S. Shering A. & Yates C. M. Effects of choline and lecithin on CSF choline levels and on cognitive functioning in patients with presenile dementia of the Alzheimer type. Nutrition and the brain 1979;5

Detopoulou, P., Panagiotakos, D. B., Antonopoulou, S., Pitsavos, C., and Stefanadis, C. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am.J.Clin.Nutr. 2008;87(2):424-430.

Etienne, P., Gauthier, S., Johnson, G., Collier, B., Mendis, T., Dastoor, D., Cole, M., and Muller, H. F. Clinical effects of choline in Alzheimer's disease. Lancet 3-4-1978;1(8062):508-509.

Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010;65(2):165-77

Liu G, Weinger JG, Lu ZL, et al. Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis. 2015;49(4):971-90.

Basheer MP, Pradeep Kumar KM, Sreekumaran E, et al. A study of serum magnesium, calcium and phosphorus level, and cognition in the elderly population of South India. Alexandria J Med.

Li W, Yu J, Liu Y, et al. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model. J Neurosci. 2013;33(19):8423-41.

Ambrose, ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res. 2001;25(1):112-16.

Costantini A, Pala MI. Thiamine and fatigue in inflammatory bowel diseases: an open-label pilot study. J Altern Complement Med. 2013;19(8):704-8.

Gibson GE, Blass JP. Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxid Redox Signal. 2007 Aug 8;

Mattson MP, Kruman II, Duan W. Folic acid and homocysteine in age-related disease. Aging Res Rev. 2002;1:95–111.

Brocardo PS, Budni J, Kaster MP, Santos AR, Rodriques AL. Folic acid administration produces an antidepressant-like effect in mice: Evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology. 2008;54:464–473.

Moretti A, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A. Vitamin B12 and folate depletion in cognition: A review. Neurol India . 2004;52:310–318.